Pharma & Healthcare
Global Pet Cancer Therapeutics Market Research Report 2025
- Sep 09, 25
- ID: 496999
- Pages: 95
- Figures: 94
- Views: 5
This report aims to provide a comprehensive presentation of the global market for Pet Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Cancer Therapeutics.
The Pet Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aratana Therapeutics, Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics, Inc
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis
VetiVax
Ngelheim International GmbH
Elanco
Merial Inc
ELIAS Animal Health
Segment by Type
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
Segment by Application
Lymphoma
Mast Cell Cancer
Melanoma
Mammary
Squamous Cell Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Pet Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aratana Therapeutics, Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics, Inc
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis
VetiVax
Ngelheim International GmbH
Elanco
Merial Inc
ELIAS Animal Health
Segment by Type
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
Segment by Application
Lymphoma
Mast Cell Cancer
Melanoma
Mammary
Squamous Cell Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Combination Therapy
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Pet Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Mast Cell Cancer
1.3.4 Melanoma
1.3.5 Mammary
1.3.6 Squamous Cell Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Cancer Therapeutics Market Perspective (2020-2031)
2.2 Global Pet Cancer Therapeutics Growth Trends by Region
2.2.1 Global Pet Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pet Cancer Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Pet Cancer Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Pet Cancer Therapeutics Market Dynamics
2.3.1 Pet Cancer Therapeutics Industry Trends
2.3.2 Pet Cancer Therapeutics Market Drivers
2.3.3 Pet Cancer Therapeutics Market Challenges
2.3.4 Pet Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Cancer Therapeutics Players by Revenue
3.1.1 Global Top Pet Cancer Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Pet Cancer Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Pet Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pet Cancer Therapeutics Revenue
3.4 Global Pet Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Pet Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Cancer Therapeutics Revenue in 2024
3.5 Global Key Players of Pet Cancer Therapeutics Head office and Area Served
3.6 Global Key Players of Pet Cancer Therapeutics, Product and Application
3.7 Global Key Players of Pet Cancer Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Cancer Therapeutics Breakdown Data by Type
4.1 Global Pet Cancer Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Pet Cancer Therapeutics Forecasted Market Size by Type (2026-2031)
5 Pet Cancer Therapeutics Breakdown Data by Application
5.1 Global Pet Cancer Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Pet Cancer Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pet Cancer Therapeutics Market Size (2020-2031)
6.2 North America Pet Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pet Cancer Therapeutics Market Size by Country (2020-2025)
6.4 North America Pet Cancer Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Cancer Therapeutics Market Size (2020-2031)
7.2 Europe Pet Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pet Cancer Therapeutics Market Size by Country (2020-2025)
7.4 Europe Pet Cancer Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Cancer Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Pet Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pet Cancer Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Pet Cancer Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Cancer Therapeutics Market Size (2020-2031)
9.2 Latin America Pet Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pet Cancer Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Pet Cancer Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Cancer Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Pet Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pet Cancer Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Pet Cancer Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aratana Therapeutics, Inc
11.1.1 Aratana Therapeutics, Inc Company Details
11.1.2 Aratana Therapeutics, Inc Business Overview
11.1.3 Aratana Therapeutics, Inc Pet Cancer Therapeutics Introduction
11.1.4 Aratana Therapeutics, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.1.5 Aratana Therapeutics, Inc Recent Development
11.2 AB Science
11.2.1 AB Science Company Details
11.2.2 AB Science Business Overview
11.2.3 AB Science Pet Cancer Therapeutics Introduction
11.2.4 AB Science Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.2.5 AB Science Recent Development
11.3 Boehringer Ingelheim International GmbH
11.3.1 Boehringer Ingelheim International GmbH Company Details
11.3.2 Boehringer Ingelheim International GmbH Business Overview
11.3.3 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Introduction
11.3.4 Boehringer Ingelheim International GmbH Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.3.5 Boehringer Ingelheim International GmbH Recent Development
11.4 Zenoaq
11.4.1 Zenoaq Company Details
11.4.2 Zenoaq Business Overview
11.4.3 Zenoaq Pet Cancer Therapeutics Introduction
11.4.4 Zenoaq Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.4.5 Zenoaq Recent Development
11.5 Morphogenesis, Inc
11.5.1 Morphogenesis, Inc Company Details
11.5.2 Morphogenesis, Inc Business Overview
11.5.3 Morphogenesis, Inc Pet Cancer Therapeutics Introduction
11.5.4 Morphogenesis, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.5.5 Morphogenesis, Inc Recent Development
11.6 VetDC, Inc
11.6.1 VetDC, Inc Company Details
11.6.2 VetDC, Inc Business Overview
11.6.3 VetDC, Inc Pet Cancer Therapeutics Introduction
11.6.4 VetDC, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.6.5 VetDC, Inc Recent Development
11.7 Karyopharm Therapeutics, Inc
11.7.1 Karyopharm Therapeutics, Inc Company Details
11.7.2 Karyopharm Therapeutics, Inc Business Overview
11.7.3 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Introduction
11.7.4 Karyopharm Therapeutics, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.7.5 Karyopharm Therapeutics, Inc Recent Development
11.8 Rhizen Pharmaceutical SA
11.8.1 Rhizen Pharmaceutical SA Company Details
11.8.2 Rhizen Pharmaceutical SA Business Overview
11.8.3 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Introduction
11.8.4 Rhizen Pharmaceutical SA Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.8.5 Rhizen Pharmaceutical SA Recent Development
11.9 Regeneus Ltd.
11.9.1 Regeneus Ltd. Company Details
11.9.2 Regeneus Ltd. Business Overview
11.9.3 Regeneus Ltd. Pet Cancer Therapeutics Introduction
11.9.4 Regeneus Ltd. Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.9.5 Regeneus Ltd. Recent Development
11.10 Oasmia Pharmaceuticals AB
11.10.1 Oasmia Pharmaceuticals AB Company Details
11.10.2 Oasmia Pharmaceuticals AB Business Overview
11.10.3 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Introduction
11.10.4 Oasmia Pharmaceuticals AB Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.10.5 Oasmia Pharmaceuticals AB Recent Development
11.11 Zoetis
11.11.1 Zoetis Company Details
11.11.2 Zoetis Business Overview
11.11.3 Zoetis Pet Cancer Therapeutics Introduction
11.11.4 Zoetis Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.11.5 Zoetis Recent Development
11.12 VetiVax
11.12.1 VetiVax Company Details
11.12.2 VetiVax Business Overview
11.12.3 VetiVax Pet Cancer Therapeutics Introduction
11.12.4 VetiVax Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.12.5 VetiVax Recent Development
11.13 Ngelheim International GmbH
11.13.1 Ngelheim International GmbH Company Details
11.13.2 Ngelheim International GmbH Business Overview
11.13.3 Ngelheim International GmbH Pet Cancer Therapeutics Introduction
11.13.4 Ngelheim International GmbH Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.13.5 Ngelheim International GmbH Recent Development
11.14 Elanco
11.14.1 Elanco Company Details
11.14.2 Elanco Business Overview
11.14.3 Elanco Pet Cancer Therapeutics Introduction
11.14.4 Elanco Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.14.5 Elanco Recent Development
11.15 Merial Inc
11.15.1 Merial Inc Company Details
11.15.2 Merial Inc Business Overview
11.15.3 Merial Inc Pet Cancer Therapeutics Introduction
11.15.4 Merial Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.15.5 Merial Inc Recent Development
11.16 ELIAS Animal Health
11.16.1 ELIAS Animal Health Company Details
11.16.2 ELIAS Animal Health Business Overview
11.16.3 ELIAS Animal Health Pet Cancer Therapeutics Introduction
11.16.4 ELIAS Animal Health Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.16.5 ELIAS Animal Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Combination Therapy
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Pet Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Mast Cell Cancer
1.3.4 Melanoma
1.3.5 Mammary
1.3.6 Squamous Cell Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Cancer Therapeutics Market Perspective (2020-2031)
2.2 Global Pet Cancer Therapeutics Growth Trends by Region
2.2.1 Global Pet Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pet Cancer Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Pet Cancer Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Pet Cancer Therapeutics Market Dynamics
2.3.1 Pet Cancer Therapeutics Industry Trends
2.3.2 Pet Cancer Therapeutics Market Drivers
2.3.3 Pet Cancer Therapeutics Market Challenges
2.3.4 Pet Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Cancer Therapeutics Players by Revenue
3.1.1 Global Top Pet Cancer Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Pet Cancer Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Pet Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pet Cancer Therapeutics Revenue
3.4 Global Pet Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Pet Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Cancer Therapeutics Revenue in 2024
3.5 Global Key Players of Pet Cancer Therapeutics Head office and Area Served
3.6 Global Key Players of Pet Cancer Therapeutics, Product and Application
3.7 Global Key Players of Pet Cancer Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Cancer Therapeutics Breakdown Data by Type
4.1 Global Pet Cancer Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Pet Cancer Therapeutics Forecasted Market Size by Type (2026-2031)
5 Pet Cancer Therapeutics Breakdown Data by Application
5.1 Global Pet Cancer Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Pet Cancer Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pet Cancer Therapeutics Market Size (2020-2031)
6.2 North America Pet Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pet Cancer Therapeutics Market Size by Country (2020-2025)
6.4 North America Pet Cancer Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Cancer Therapeutics Market Size (2020-2031)
7.2 Europe Pet Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pet Cancer Therapeutics Market Size by Country (2020-2025)
7.4 Europe Pet Cancer Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Cancer Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Pet Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pet Cancer Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Pet Cancer Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Cancer Therapeutics Market Size (2020-2031)
9.2 Latin America Pet Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pet Cancer Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Pet Cancer Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Cancer Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Pet Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pet Cancer Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Pet Cancer Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aratana Therapeutics, Inc
11.1.1 Aratana Therapeutics, Inc Company Details
11.1.2 Aratana Therapeutics, Inc Business Overview
11.1.3 Aratana Therapeutics, Inc Pet Cancer Therapeutics Introduction
11.1.4 Aratana Therapeutics, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.1.5 Aratana Therapeutics, Inc Recent Development
11.2 AB Science
11.2.1 AB Science Company Details
11.2.2 AB Science Business Overview
11.2.3 AB Science Pet Cancer Therapeutics Introduction
11.2.4 AB Science Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.2.5 AB Science Recent Development
11.3 Boehringer Ingelheim International GmbH
11.3.1 Boehringer Ingelheim International GmbH Company Details
11.3.2 Boehringer Ingelheim International GmbH Business Overview
11.3.3 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Introduction
11.3.4 Boehringer Ingelheim International GmbH Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.3.5 Boehringer Ingelheim International GmbH Recent Development
11.4 Zenoaq
11.4.1 Zenoaq Company Details
11.4.2 Zenoaq Business Overview
11.4.3 Zenoaq Pet Cancer Therapeutics Introduction
11.4.4 Zenoaq Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.4.5 Zenoaq Recent Development
11.5 Morphogenesis, Inc
11.5.1 Morphogenesis, Inc Company Details
11.5.2 Morphogenesis, Inc Business Overview
11.5.3 Morphogenesis, Inc Pet Cancer Therapeutics Introduction
11.5.4 Morphogenesis, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.5.5 Morphogenesis, Inc Recent Development
11.6 VetDC, Inc
11.6.1 VetDC, Inc Company Details
11.6.2 VetDC, Inc Business Overview
11.6.3 VetDC, Inc Pet Cancer Therapeutics Introduction
11.6.4 VetDC, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.6.5 VetDC, Inc Recent Development
11.7 Karyopharm Therapeutics, Inc
11.7.1 Karyopharm Therapeutics, Inc Company Details
11.7.2 Karyopharm Therapeutics, Inc Business Overview
11.7.3 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Introduction
11.7.4 Karyopharm Therapeutics, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.7.5 Karyopharm Therapeutics, Inc Recent Development
11.8 Rhizen Pharmaceutical SA
11.8.1 Rhizen Pharmaceutical SA Company Details
11.8.2 Rhizen Pharmaceutical SA Business Overview
11.8.3 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Introduction
11.8.4 Rhizen Pharmaceutical SA Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.8.5 Rhizen Pharmaceutical SA Recent Development
11.9 Regeneus Ltd.
11.9.1 Regeneus Ltd. Company Details
11.9.2 Regeneus Ltd. Business Overview
11.9.3 Regeneus Ltd. Pet Cancer Therapeutics Introduction
11.9.4 Regeneus Ltd. Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.9.5 Regeneus Ltd. Recent Development
11.10 Oasmia Pharmaceuticals AB
11.10.1 Oasmia Pharmaceuticals AB Company Details
11.10.2 Oasmia Pharmaceuticals AB Business Overview
11.10.3 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Introduction
11.10.4 Oasmia Pharmaceuticals AB Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.10.5 Oasmia Pharmaceuticals AB Recent Development
11.11 Zoetis
11.11.1 Zoetis Company Details
11.11.2 Zoetis Business Overview
11.11.3 Zoetis Pet Cancer Therapeutics Introduction
11.11.4 Zoetis Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.11.5 Zoetis Recent Development
11.12 VetiVax
11.12.1 VetiVax Company Details
11.12.2 VetiVax Business Overview
11.12.3 VetiVax Pet Cancer Therapeutics Introduction
11.12.4 VetiVax Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.12.5 VetiVax Recent Development
11.13 Ngelheim International GmbH
11.13.1 Ngelheim International GmbH Company Details
11.13.2 Ngelheim International GmbH Business Overview
11.13.3 Ngelheim International GmbH Pet Cancer Therapeutics Introduction
11.13.4 Ngelheim International GmbH Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.13.5 Ngelheim International GmbH Recent Development
11.14 Elanco
11.14.1 Elanco Company Details
11.14.2 Elanco Business Overview
11.14.3 Elanco Pet Cancer Therapeutics Introduction
11.14.4 Elanco Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.14.5 Elanco Recent Development
11.15 Merial Inc
11.15.1 Merial Inc Company Details
11.15.2 Merial Inc Business Overview
11.15.3 Merial Inc Pet Cancer Therapeutics Introduction
11.15.4 Merial Inc Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.15.5 Merial Inc Recent Development
11.16 ELIAS Animal Health
11.16.1 ELIAS Animal Health Company Details
11.16.2 ELIAS Animal Health Business Overview
11.16.3 ELIAS Animal Health Pet Cancer Therapeutics Introduction
11.16.4 ELIAS Animal Health Revenue in Pet Cancer Therapeutics Business (2020-2025)
11.16.5 ELIAS Animal Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pet Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Combination Therapy
Table 5. Key Players of Immunotherapy
Table 6. Global Pet Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pet Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pet Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pet Cancer Therapeutics Market Share by Region (2020-2025)
Table 10. Global Pet Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pet Cancer Therapeutics Market Share by Region (2026-2031)
Table 12. Pet Cancer Therapeutics Market Trends
Table 13. Pet Cancer Therapeutics Market Drivers
Table 14. Pet Cancer Therapeutics Market Challenges
Table 15. Pet Cancer Therapeutics Market Restraints
Table 16. Global Pet Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pet Cancer Therapeutics Market Share by Players (2020-2025)
Table 18. Global Top Pet Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Cancer Therapeutics as of 2024)
Table 19. Ranking of Global Top Pet Cancer Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pet Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pet Cancer Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Pet Cancer Therapeutics, Product and Application
Table 23. Global Key Players of Pet Cancer Therapeutics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pet Cancer Therapeutics Revenue Market Share by Type (2020-2025)
Table 27. Global Pet Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pet Cancer Therapeutics Revenue Market Share by Type (2026-2031)
Table 29. Global Pet Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pet Cancer Therapeutics Revenue Market Share by Application (2020-2025)
Table 31. Global Pet Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pet Cancer Therapeutics Revenue Market Share by Application (2026-2031)
Table 33. North America Pet Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pet Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pet Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pet Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pet Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pet Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pet Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pet Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pet Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pet Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pet Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pet Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pet Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pet Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pet Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Aratana Therapeutics, Inc Company Details
Table 49. Aratana Therapeutics, Inc Business Overview
Table 50. Aratana Therapeutics, Inc Pet Cancer Therapeutics Product
Table 51. Aratana Therapeutics, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 52. Aratana Therapeutics, Inc Recent Development
Table 53. AB Science Company Details
Table 54. AB Science Business Overview
Table 55. AB Science Pet Cancer Therapeutics Product
Table 56. AB Science Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 57. AB Science Recent Development
Table 58. Boehringer Ingelheim International GmbH Company Details
Table 59. Boehringer Ingelheim International GmbH Business Overview
Table 60. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product
Table 61. Boehringer Ingelheim International GmbH Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 62. Boehringer Ingelheim International GmbH Recent Development
Table 63. Zenoaq Company Details
Table 64. Zenoaq Business Overview
Table 65. Zenoaq Pet Cancer Therapeutics Product
Table 66. Zenoaq Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 67. Zenoaq Recent Development
Table 68. Morphogenesis, Inc Company Details
Table 69. Morphogenesis, Inc Business Overview
Table 70. Morphogenesis, Inc Pet Cancer Therapeutics Product
Table 71. Morphogenesis, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 72. Morphogenesis, Inc Recent Development
Table 73. VetDC, Inc Company Details
Table 74. VetDC, Inc Business Overview
Table 75. VetDC, Inc Pet Cancer Therapeutics Product
Table 76. VetDC, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 77. VetDC, Inc Recent Development
Table 78. Karyopharm Therapeutics, Inc Company Details
Table 79. Karyopharm Therapeutics, Inc Business Overview
Table 80. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product
Table 81. Karyopharm Therapeutics, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 82. Karyopharm Therapeutics, Inc Recent Development
Table 83. Rhizen Pharmaceutical SA Company Details
Table 84. Rhizen Pharmaceutical SA Business Overview
Table 85. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product
Table 86. Rhizen Pharmaceutical SA Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 87. Rhizen Pharmaceutical SA Recent Development
Table 88. Regeneus Ltd. Company Details
Table 89. Regeneus Ltd. Business Overview
Table 90. Regeneus Ltd. Pet Cancer Therapeutics Product
Table 91. Regeneus Ltd. Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 92. Regeneus Ltd. Recent Development
Table 93. Oasmia Pharmaceuticals AB Company Details
Table 94. Oasmia Pharmaceuticals AB Business Overview
Table 95. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product
Table 96. Oasmia Pharmaceuticals AB Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 97. Oasmia Pharmaceuticals AB Recent Development
Table 98. Zoetis Company Details
Table 99. Zoetis Business Overview
Table 100. Zoetis Pet Cancer Therapeutics Product
Table 101. Zoetis Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 102. Zoetis Recent Development
Table 103. VetiVax Company Details
Table 104. VetiVax Business Overview
Table 105. VetiVax Pet Cancer Therapeutics Product
Table 106. VetiVax Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 107. VetiVax Recent Development
Table 108. Ngelheim International GmbH Company Details
Table 109. Ngelheim International GmbH Business Overview
Table 110. Ngelheim International GmbH Pet Cancer Therapeutics Product
Table 111. Ngelheim International GmbH Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 112. Ngelheim International GmbH Recent Development
Table 113. Elanco Company Details
Table 114. Elanco Business Overview
Table 115. Elanco Pet Cancer Therapeutics Product
Table 116. Elanco Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 117. Elanco Recent Development
Table 118. Merial Inc Company Details
Table 119. Merial Inc Business Overview
Table 120. Merial Inc Pet Cancer Therapeutics Product
Table 121. Merial Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 122. Merial Inc Recent Development
Table 123. ELIAS Animal Health Company Details
Table 124. ELIAS Animal Health Business Overview
Table 125. ELIAS Animal Health Pet Cancer Therapeutics Product
Table 126. ELIAS Animal Health Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 127. ELIAS Animal Health Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Pet Cancer Therapeutics Picture
Figure 2. Global Pet Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pet Cancer Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Targeted Therapy Features
Figure 6. Combination Therapy Features
Figure 7. Immunotherapy Features
Figure 8. Global Pet Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pet Cancer Therapeutics Market Share by Application: 2024 VS 2031
Figure 10. Lymphoma Case Studies
Figure 11. Mast Cell Cancer Case Studies
Figure 12. Melanoma Case Studies
Figure 13. Mammary Case Studies
Figure 14. Squamous Cell Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Pet Cancer Therapeutics Report Years Considered
Figure 17. Global Pet Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Pet Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Pet Cancer Therapeutics Market Share by Region: 2024 VS 2031
Figure 20. Global Pet Cancer Therapeutics Market Share by Players in 2024
Figure 21. Global Top Pet Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Cancer Therapeutics as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Pet Cancer Therapeutics Revenue in 2024
Figure 23. North America Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Pet Cancer Therapeutics Market Share by Country (2020-2031)
Figure 25. United States Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Pet Cancer Therapeutics Market Share by Country (2020-2031)
Figure 29. Germany Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Pet Cancer Therapeutics Market Share by Region (2020-2031)
Figure 37. China Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Pet Cancer Therapeutics Market Share by Country (2020-2031)
Figure 45. Mexico Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Pet Cancer Therapeutics Market Share by Country (2020-2031)
Figure 49. Turkey Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Aratana Therapeutics, Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 53. AB Science Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 54. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 55. Zenoaq Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 56. Morphogenesis, Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 57. VetDC, Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 58. Karyopharm Therapeutics, Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 59. Rhizen Pharmaceutical SA Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 60. Regeneus Ltd. Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 61. Oasmia Pharmaceuticals AB Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 62. Zoetis Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 63. VetiVax Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 64. Ngelheim International GmbH Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 65. Elanco Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 66. Merial Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 67. ELIAS Animal Health Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Pet Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Combination Therapy
Table 5. Key Players of Immunotherapy
Table 6. Global Pet Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pet Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pet Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pet Cancer Therapeutics Market Share by Region (2020-2025)
Table 10. Global Pet Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pet Cancer Therapeutics Market Share by Region (2026-2031)
Table 12. Pet Cancer Therapeutics Market Trends
Table 13. Pet Cancer Therapeutics Market Drivers
Table 14. Pet Cancer Therapeutics Market Challenges
Table 15. Pet Cancer Therapeutics Market Restraints
Table 16. Global Pet Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pet Cancer Therapeutics Market Share by Players (2020-2025)
Table 18. Global Top Pet Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Cancer Therapeutics as of 2024)
Table 19. Ranking of Global Top Pet Cancer Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pet Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pet Cancer Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Pet Cancer Therapeutics, Product and Application
Table 23. Global Key Players of Pet Cancer Therapeutics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pet Cancer Therapeutics Revenue Market Share by Type (2020-2025)
Table 27. Global Pet Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pet Cancer Therapeutics Revenue Market Share by Type (2026-2031)
Table 29. Global Pet Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pet Cancer Therapeutics Revenue Market Share by Application (2020-2025)
Table 31. Global Pet Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pet Cancer Therapeutics Revenue Market Share by Application (2026-2031)
Table 33. North America Pet Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pet Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pet Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pet Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pet Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pet Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pet Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pet Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pet Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pet Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pet Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pet Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pet Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pet Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pet Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Aratana Therapeutics, Inc Company Details
Table 49. Aratana Therapeutics, Inc Business Overview
Table 50. Aratana Therapeutics, Inc Pet Cancer Therapeutics Product
Table 51. Aratana Therapeutics, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 52. Aratana Therapeutics, Inc Recent Development
Table 53. AB Science Company Details
Table 54. AB Science Business Overview
Table 55. AB Science Pet Cancer Therapeutics Product
Table 56. AB Science Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 57. AB Science Recent Development
Table 58. Boehringer Ingelheim International GmbH Company Details
Table 59. Boehringer Ingelheim International GmbH Business Overview
Table 60. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product
Table 61. Boehringer Ingelheim International GmbH Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 62. Boehringer Ingelheim International GmbH Recent Development
Table 63. Zenoaq Company Details
Table 64. Zenoaq Business Overview
Table 65. Zenoaq Pet Cancer Therapeutics Product
Table 66. Zenoaq Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 67. Zenoaq Recent Development
Table 68. Morphogenesis, Inc Company Details
Table 69. Morphogenesis, Inc Business Overview
Table 70. Morphogenesis, Inc Pet Cancer Therapeutics Product
Table 71. Morphogenesis, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 72. Morphogenesis, Inc Recent Development
Table 73. VetDC, Inc Company Details
Table 74. VetDC, Inc Business Overview
Table 75. VetDC, Inc Pet Cancer Therapeutics Product
Table 76. VetDC, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 77. VetDC, Inc Recent Development
Table 78. Karyopharm Therapeutics, Inc Company Details
Table 79. Karyopharm Therapeutics, Inc Business Overview
Table 80. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product
Table 81. Karyopharm Therapeutics, Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 82. Karyopharm Therapeutics, Inc Recent Development
Table 83. Rhizen Pharmaceutical SA Company Details
Table 84. Rhizen Pharmaceutical SA Business Overview
Table 85. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product
Table 86. Rhizen Pharmaceutical SA Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 87. Rhizen Pharmaceutical SA Recent Development
Table 88. Regeneus Ltd. Company Details
Table 89. Regeneus Ltd. Business Overview
Table 90. Regeneus Ltd. Pet Cancer Therapeutics Product
Table 91. Regeneus Ltd. Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 92. Regeneus Ltd. Recent Development
Table 93. Oasmia Pharmaceuticals AB Company Details
Table 94. Oasmia Pharmaceuticals AB Business Overview
Table 95. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product
Table 96. Oasmia Pharmaceuticals AB Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 97. Oasmia Pharmaceuticals AB Recent Development
Table 98. Zoetis Company Details
Table 99. Zoetis Business Overview
Table 100. Zoetis Pet Cancer Therapeutics Product
Table 101. Zoetis Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 102. Zoetis Recent Development
Table 103. VetiVax Company Details
Table 104. VetiVax Business Overview
Table 105. VetiVax Pet Cancer Therapeutics Product
Table 106. VetiVax Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 107. VetiVax Recent Development
Table 108. Ngelheim International GmbH Company Details
Table 109. Ngelheim International GmbH Business Overview
Table 110. Ngelheim International GmbH Pet Cancer Therapeutics Product
Table 111. Ngelheim International GmbH Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 112. Ngelheim International GmbH Recent Development
Table 113. Elanco Company Details
Table 114. Elanco Business Overview
Table 115. Elanco Pet Cancer Therapeutics Product
Table 116. Elanco Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 117. Elanco Recent Development
Table 118. Merial Inc Company Details
Table 119. Merial Inc Business Overview
Table 120. Merial Inc Pet Cancer Therapeutics Product
Table 121. Merial Inc Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 122. Merial Inc Recent Development
Table 123. ELIAS Animal Health Company Details
Table 124. ELIAS Animal Health Business Overview
Table 125. ELIAS Animal Health Pet Cancer Therapeutics Product
Table 126. ELIAS Animal Health Revenue in Pet Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 127. ELIAS Animal Health Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Pet Cancer Therapeutics Picture
Figure 2. Global Pet Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pet Cancer Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Targeted Therapy Features
Figure 6. Combination Therapy Features
Figure 7. Immunotherapy Features
Figure 8. Global Pet Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pet Cancer Therapeutics Market Share by Application: 2024 VS 2031
Figure 10. Lymphoma Case Studies
Figure 11. Mast Cell Cancer Case Studies
Figure 12. Melanoma Case Studies
Figure 13. Mammary Case Studies
Figure 14. Squamous Cell Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Pet Cancer Therapeutics Report Years Considered
Figure 17. Global Pet Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Pet Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Pet Cancer Therapeutics Market Share by Region: 2024 VS 2031
Figure 20. Global Pet Cancer Therapeutics Market Share by Players in 2024
Figure 21. Global Top Pet Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Cancer Therapeutics as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Pet Cancer Therapeutics Revenue in 2024
Figure 23. North America Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Pet Cancer Therapeutics Market Share by Country (2020-2031)
Figure 25. United States Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Pet Cancer Therapeutics Market Share by Country (2020-2031)
Figure 29. Germany Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Pet Cancer Therapeutics Market Share by Region (2020-2031)
Figure 37. China Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Pet Cancer Therapeutics Market Share by Country (2020-2031)
Figure 45. Mexico Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Pet Cancer Therapeutics Market Share by Country (2020-2031)
Figure 49. Turkey Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Pet Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Aratana Therapeutics, Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 53. AB Science Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 54. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 55. Zenoaq Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 56. Morphogenesis, Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 57. VetDC, Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 58. Karyopharm Therapeutics, Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 59. Rhizen Pharmaceutical SA Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 60. Regeneus Ltd. Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 61. Oasmia Pharmaceuticals AB Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 62. Zoetis Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 63. VetiVax Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 64. Ngelheim International GmbH Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 65. Elanco Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 66. Merial Inc Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 67. ELIAS Animal Health Revenue Growth Rate in Pet Cancer Therapeutics Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232